Optimizing care for patients with CKM syndrome: A multidisciplinary approach

EBAC-accredited Satellite Symposium during ESC Congress 2024, London, United Kingdom

Live Meeting
1.00 available credits
Information
September 1, 2024
12:30 - 13:30 BST
ExCel London, United Kingdom
Room Belgrade
Details
Presenters
Comments
  • Overview

    Invitation to the EBAC-accredited Satellite Symposium "Optimizing care for patients with Cardiovascular-Kidney-Metabolic (CKM) syndrome: A multidisciplinary approach"

    For more information, please visit the ESC website.

    Educational objectives

    The educational objectives of the symposium are to:

    • Apply the CKM staging framework to identify and classify patients at different levels of syndromic severity
    • Utilize CKM risk prediction algorithms that prioritize cardiorenal health to guide clinical decision-making
    • Develop comprehensive, guideline-concordant treatment plans for patients with CKM syndrome, incorporating lifestyle interventions, appropriate pharmacological therapies, and interdisciplinary care approaches
    • Integrate the latest clinical trial data and guideline recommendations to optimize cardiovascular risk reduction strategies in patients with type 2 diabetes and chronic kidney disease

    Agenda

    12:30 – 12:35    Welcome and introduction - Carolyn Lam, MD, PhD - Singapore

    12:35 – 12:45    Definition and staging of CKM syndrome - Carolyn Lam, MD, PhD - Singapore

    12:45– 12:55     Screening for CKM syndrome - Jürgen Floege, MD – Aachen, Germanye

    12:55 – 13:05    Comprehensive management of individuals with CKM syndrome - Muthiah Vaduganathan, MD – Boston, MA, US

    13:05 – 13:15    Case-based learning and future directions - All faculty

    13:15 – 13:30    Panel discussion and Q&A - All faculty

    CME Accreditation

    This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 60 minutes effective education time.  Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

    Funding

    This programme is sponsored by Bayer AG and is intended for Healthcare Professionals outside the UK only.  It is not intended for a UK audience. 
    Bayer AG have not influenced or been involved with the development of the content of the programme.

Details
Presenters
Comments
  • Overview

    Invitation to the EBAC-accredited Satellite Symposium "Optimizing care for patients with Cardiovascular-Kidney-Metabolic (CKM) syndrome: A multidisciplinary approach"

    For more information, please visit the ESC website.

    Educational objectives

    The educational objectives of the symposium are to:

    • Apply the CKM staging framework to identify and classify patients at different levels of syndromic severity
    • Utilize CKM risk prediction algorithms that prioritize cardiorenal health to guide clinical decision-making
    • Develop comprehensive, guideline-concordant treatment plans for patients with CKM syndrome, incorporating lifestyle interventions, appropriate pharmacological therapies, and interdisciplinary care approaches
    • Integrate the latest clinical trial data and guideline recommendations to optimize cardiovascular risk reduction strategies in patients with type 2 diabetes and chronic kidney disease

    Agenda

    12:30 – 12:35    Welcome and introduction - Carolyn Lam, MD, PhD - Singapore

    12:35 – 12:45    Definition and staging of CKM syndrome - Carolyn Lam, MD, PhD - Singapore

    12:45– 12:55     Screening for CKM syndrome - Jürgen Floege, MD – Aachen, Germanye

    12:55 – 13:05    Comprehensive management of individuals with CKM syndrome - Muthiah Vaduganathan, MD – Boston, MA, US

    13:05 – 13:15    Case-based learning and future directions - All faculty

    13:15 – 13:30    Panel discussion and Q&A - All faculty

    CME Accreditation

    This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 60 minutes effective education time.  Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

    Funding

    This programme is sponsored by Bayer AG and is intended for Healthcare Professionals outside the UK only.  It is not intended for a UK audience. 
    Bayer AG have not influenced or been involved with the development of the content of the programme.

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free